Skip to main content
search

Drug Interactions

The Anesthesia Guide » Topics » Drug Interactions

Author:
Kai Knudsen



Updated:
13 February, 2026

Overview of clinically relevant drug interactions in anesthesia and intensive care – including anticoagulants, cardiovascular medications, neuromuscular blocking agents, electrolyte disturbances, and practical perioperative principles.

Content:
  1. Anesthesia-Specific Drug Interaction Summary
  2. Anticoagulants & Antiplatelets
  3. Warfarin + CYP Inhibitors (e.g., Metronidazole)
  4. Clopidogrel + Omeprazole
  5. Cardiovascular Drugs
  6. Digoxin + Verapamil
  7. Beta-blockers + Anesthetic Agents
  8. Neuromuscular Blockade Interactions
  9. Lithium + Neuromuscular Blockers
  10. Magnesium + Neuromuscular Blockers
  11. Antibiotics & CYP Interactions
  12. Clarithromycin + Statins
  13. Ciprofloxacin + Theophylline
  14. Metformin + IV Contrast / Hypoperfusion
  15. CNS-Active Drugs
  16. Isotretinoin + Tetracyclines
  17. Levodopa + Pyridoxine (without carbidopa)
  18. Electrolyte-Mediated Interactions
  19. ICU Amplifiers of Drug Interactions
  20. High-Yield “Red Flag” Combinations for Anesthesia
  21. Practical Anesthesia Principles

Anesthesia-Specific Drug Interaction Summary

In anesthesia, drug interactions become critical because:

  • Hemodynamic reserve may be limited
  • Ventilation is controlled
  • Polypharmacy is common
  • Renal and hepatic perfusion may be impaired

Below are the most clinically relevant interactions for anesthesiologists.

Anticoagulants & Antiplatelets

Warfarin + CYP Inhibitors (e.g., Metronidazole)

→ Increased INR → bleeding risk

Anesthetic relevance:

  • Contraindication to neuraxial anesthesia if INR elevated
  • Increased surgical bleeding
  • Need for perioperative bridging strategy

Clopidogrel + Omeprazole

→ Reduced antiplatelet effect

Relevance:

  • Increased risk of stent thrombosis
  • Critical within 3–6 months post-PCI
  • Preoperative medication reconciliation essential

Cardiovascular Drugs

Digoxin + Verapamil

→ Digoxin toxicity

Risk intraoperatively:

  • Bradycardia
  • AV block
  • Hemodynamic instability

Practical approach:

  • Continuous ECG monitoring
  • Avoid adding other AV nodal blockers

Beta-blockers + Anesthetic Agents

→ Exaggerated hypotension and bradycardia

Risk:

  • Blunted sympathetic response
  • Reduced cardiac output

Key principle:

  • Continue chronic beta-blockade
  • Be prepared for vasopressor support

Neuromuscular Blockade Interactions

Lithium + Neuromuscular Blockers

→ Prolonged blockade

Mechanism:

Lithium interferes with neuromuscular transmission.

Clinical implication:

  • Reduce dose of nondepolarizing agents
  • Monitor with TOF

Magnesium + Neuromuscular Blockers

→ Potentiation of blockade

Common ICU scenario:

  • Eclampsia treatment
  • Hypomagnesemia correction

Risk:

  • Prolonged paralysis
  • Postoperative respiratory failure

Antibiotics & CYP Interactions

Clarithromycin + Statins

→ Rhabdomyolysis → AKI

ICU relevance:

  • Hyperkalemia
  • Arrhythmias
  • Renal dysfunction affecting drug clearance

Ciprofloxacin + Theophylline

→ Seizures and arrhythmias

Anesthesia risk:

  • Increased arrhythmogenic potential
  • Increased CNS excitability

Metformin + IV Contrast / Hypoperfusion

→ Lactic acidosis

High-risk scenario:

  • Sepsis
  • Shock
  • Major surgery

Practical:

  • Hold metformin preoperatively in high-risk patients
  • Monitor lactate

CNS-Active Drugs

Isotretinoin + Tetracyclines

→ Intracranial hypertension

Neuroanesthesia relevance:

  • Elevated ICP
  • Risk during intracranial procedures

Levodopa + Pyridoxine (without carbidopa)

→ Reduced levodopa efficacy

Perioperative issue:

  • Parkinsonian rigidity
  • Increased aspiration risk

Electrolyte-Mediated Interactions

Many drug interactions are amplified by electrolyte disturbances:

  • Hypokalemia → Increased digoxin toxicity
  • Hyperkalemia → Increased arrhythmia risk
  • Hypomagnesemia → Torsades risk
  • Hypocalcemia → Reduced myocardial contractility

Always interpret drug effects in context of electrolyte status.

ICU Amplifiers of Drug Interactions

  • Renal failure → decreased drug clearance
  • Hepatic dysfunction → altered metabolism
  • Hypoalbuminemia → increased free drug fraction
  • Hypothermia → altered pharmacokinetics

High-Yield “Red Flag” Combinations for Anesthesia

CombinationMajor Risk
Warfarin + CYP inhibitorBleeding
Lithium + NMBProlonged paralysis
Magnesium + NMBProlonged paralysis
Statin + MacrolideRhabdomyolysis
Metformin + ShockLactic acidosis
Digoxin + VerapamilAV block

Practical Anesthesia Principles

  1. Always review the medication list before induction.
  2. Anticipate altered drug sensitivity.
  3. Use neuromuscular monitoring when risk exists.
  4. Monitor ECG in high-risk interactions.
  5. Adjust doses in renal/hepatic dysfunction.

 

Disclaimer:

The content on AnesthGuide.com is intended for use by medical professionals and is based on practices and guidelines within the Swedish healthcare context.

While all articles are reviewed by experienced professionals, the information provided may not be error-free or universally applicable.

Users are advised to always apply their professional judgment and consult relevant local guidelines.

By using this site, you agree to our Terms of Use.




Close Menu